Back
Jasper Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
33
JSPR
Jasper Therapeutics
Last Price:
20.68
Seasonality Move:
102.65%
Sell
20
NBY
NovaBay Pharmaceuticals
Last Price:
0.58
Seasonality Move:
-8.54%
Sell
33
Jasper Therapeutics (JSPR)
is a Sell
Is Jasper Therapeutics a Buy, Sell or Hold?
- The current Jasper Therapeutics [JSPR] share price is $20.47. The Score for JSPR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- JSPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.56. The Score for NBY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
JSPR Stock Price Chart
What is Jasper Therapeutics's stock price today?
-
The Jasper Therapeutics share price today is $20.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JSPR is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
JSPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 41.66 | Sell |
Chaikin Money Flow: | -121093 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.2 - 23.64) | Sell |
Bollinger Bands (100): | (17.65 - 22.55) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 37.85 | Sell |
Chaikin Money Flow: | 45726 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.58 - 0.72) | Sell |
Bollinger Bands (100): | (0.37 - 0.91) | Sell |
JSPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.3 | Sell |
20-day SMA: | 22.09 | Sell |
50-day SMA: | 20.77 | Sell |
200-day SMA: | 22.05 | Sell |
8-day EMA: | 22.05 | Sell |
20-day EMA: | 22.16 | Sell |
50-day EMA: | 21.47 | Sell |
200-day EMA: | 20.03 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.57 | Sell |
20-day SMA: | 0.63 | Sell |
50-day SMA: | 0.65 | Sell |
200-day SMA: | 2.02 | Sell |
8-day EMA: | 0.58 | Sell |
20-day EMA: | 0.61 | Sell |
50-day EMA: | 0.67 | Sell |
200-day EMA: | 4.96 | Sell |
Jasper Therapeutics Earnings Growth & JSPR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and a decrease next year of $0.14 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Jasper Therapeutics Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |